|
ZMYM3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.354600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.136200E-01 |
| Normal-vs-Stage2 |
8.608000E-01 |
| Normal-vs-Stage3 |
2.805400E-01 |
| Normal-vs-Stage4 |
3.747000E-01 |
| Stage1-vs-Stage2 |
7.536000E-01 |
| Stage1-vs-Stage3 |
5.031000E-01 |
| Stage1-vs-Stage4 |
6.877000E-01 |
| Stage2-vs-Stage3 |
4.988200E-01 |
| Stage2-vs-Stage4 |
5.800000E-01 |
| Stage3-vs-Stage4 |
9.179600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.134400E-01 |
| Normal-vs-AfricanAmerican |
1.922010E-01 |
| Normal-vs-Asian |
9.435800E-01 |
| Caucasian-vs-AfricanAmerican |
4.624500E-02 |
| Caucasian-vs-Asian |
4.788000E-01 |
| AfricanAmerican-vs-Asian |
2.075600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.783600E-01 |
| Normal-vs-Female |
3.467200E-01 |
| Male-vs-Female |
3.872200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.147000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.867200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.630000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.674600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.130000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.165200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.369800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.525600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.449800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.403400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.377700E-02 |
| Classical-VS-Follicular |
1.261790E-03 |
| Classical-VS-Other |
2.201200E-01 |
| Classical-VS-Normal |
7.237400E-01 |
| Tall-VS-Follicular |
9.923200E-01 |
| Tall-VS-Other |
9.665600E-01 |
| Tall-VS-Normal |
6.650000E-02 |
| Follicular-VS-Other |
9.760800E-01 |
| Follicular-VS-Normal |
4.290400E-02 |
| Other-VS-Normal |
3.125200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.314800E-01 |
| Normal-vs-N1 |
4.910300E-02 |
| N0-vs-N1 |
8.661800E-02 |
|
|
